Chimeric bacteriocin S5-PmnH engineered by domain swapping efficiently controls Pseudomonas aeruginosa infection in murine keratitis and lung models.

Paškevičius Š, Dapkutė V, Misiūnas A, Balzaris M, Thommes P, Sattar A, Gleba Y, Ražanskienė A

Open source

DOI
10.1038/s41598-022-09865-8
Published
2022 Apr 19
Container
Scientific reports
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41598-022-09865-8,
  title = {Chimeric bacteriocin S5-PmnH engineered by domain swapping efficiently controls Pseudomonas aeruginosa infection in murine keratitis and lung models.},
  author = {Paškevičius Š and Dapkutė V and Misiūnas A and Balzaris M and Thommes P and Sattar A and Gleba Y and Ražanskienė A},
  year = {2022},
  journal = {Scientific reports},
  doi = {10.1038/s41598-022-09865-8},
  url = {https://doi.org/10.1038/s41598-022-09865-8}
}

RIS

TY  - JOUR
TI  - Chimeric bacteriocin S5-PmnH engineered by domain swapping efficiently controls Pseudomonas aeruginosa infection in murine keratitis and lung models.
AU  - Paškevičius Š
AU  - Dapkutė V
AU  - Misiūnas A
AU  - Balzaris M
AU  - Thommes P
AU  - Sattar A
AU  - Gleba Y
AU  - Ražanskienė A
PY  - 2022
JO  - Scientific reports
DO  - 10.1038/s41598-022-09865-8
UR  - https://doi.org/10.1038/s41598-022-09865-8
ER  - 

APA

Š, P., V, D., A, M., M, B., P, T., A, S., Y, G., & A, R. (2022). Chimeric bacteriocin S5-PmnH engineered by domain swapping efficiently controls Pseudomonas aeruginosa infection in murine keratitis and lung models.. Scientific reports. https://doi.org/10.1038/s41598-022-09865-8

Source records